The Vav family: At the crossroads of signaling pathways

Immunologic Research

Volumn 32, Issue 1-3, 2005, Pages 259-265

  Swat, Wojciech ^a   Fujikawa, Keiko ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antigen receptor; Ca++; Lymphocyte; Mitogen activated protein kinase; Natural killer cell

Indexed keywords

B LYMPHOCYTE RECEPTOR; CALCIUM ION; INTEGRIN; ISOPROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VAV PROTEIN; VAV PROTEIN 1; VAV PROTEIN 2; VAV PROTEIN 3;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; B LYMPHOCYTE; CALCIUM TRANSPORT; CELL ACTIVATION; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CYTOSKELETON; CYTOTOXICITY; ENZYME REGULATION; GENE REARRANGEMENT; IMMUNE SYSTEM; KNOCKOUT GENE; LEUKOCYTE ADHERENCE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; CELL ADHESION; CELL DIFFERENTIATION; CYTOSKELETON; INTEGRINS; KILLER CELLS, NATURAL; LEUKOCYTES; LYMPHOCYTES; MICE; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; PROTO-ONCOGENE PROTEINS C-VAV; RECEPTORS, ANTIGEN; SIGNAL TRANSDUCTION;

EID: 23844538589     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:32:1-3:259     Document Type: Review

References (55)

1. Bassing CH, Swat W, Alt FW: The mechanism and regulation of chromosomal V(D)J recombination. Cell 2002;109:S45-S55.
2. Borowski C, et al: On the brink of becoming a T cell. Curr Opin Immunol 2002;14:200-206.
3. + thymocytes. Proc Natl Acad Sci USA 1996;93:4683-4687.
4. Crompton T, Gilmour KC, Owen MJ: The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte. Cell 1996;86:243-251.
5. Gartner F, et al: Immature thymocytes employ distinct signaling pathways for allelic exclusion versus differentiation and expansion. Immunity 1999;10:537-546.
6. Iritani BM, et al: Distinct signals mediate maturation and allelic exclusion in lymphocyte progenitors. Immunity 1999;10:713-722.
7. Aifantis I, et al: Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-kappaB and NFAT. Nat Immunol 2001;2:403-409.
8. Iritani BM, et al: Control of B cell development by Ras-mediated activation of Raf. EMBO J 1997;16: 7019-7031.
9. Shaw AC, et al: Induction of Ig light chain gene rearrangement in heavy chain-deficient B cells by activated Ras. Proc Natl Acad Sci USA 1999;96:2239-2243.
10. Shaw AC, et al: Activated Ras signals developmental progression of recombinase-activating gene (RAG) - deficient pro-B lymphocytes. J Exp Med 1999;189:123-129.
11. Kane LP, Lin J, Weiss A: Signal transduction by the TCR for antigen. Curr Opin Immunol 2000;12:242-249.
12. Acuto O, Cantrell D: T cell activation and the cytoskeleton. Annu Rev Immunol 2000;18:165-184.
13. DeFranco AL: B-cell activation 2000. Immunol Rev 2000;176:5-9.
14. Gauld SB, Dal Porto JM, Cambier JC: B cell antigen receptor signaling: roles in cell development and disease. Science 2002;296:1641, 1642.
15. Samelson LE: Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins. Annu Rev Immunol 2002;20:371-394.
16. Koretzky GA, Myung PS: Positive and negative regulation of T-cell activation by adaptor proteins. Nat Rev Immunol 2001;1:95-107.
17. Bustelo XR: Vav proteins, adaptors and cell signaling. Oncogene 2001;20:6372-6381.
18. Turner M, Billadeau DD: VAV proteins as signal integrators for multi-subunit immune-recognition receptors. Nat Rev Immunol 2002;2:476-486.
19. Tomlinson MG, Lin J, Weiss A: Lymphocytes with a complex: adapter proteins in antigen receptor signaling. Immunol Today 2000;21:584-591.
20. Miletic AV, et al: Cytoskeletal remodeling in lymphocyte activation. Curr Opin Immunol 2003;15:261-268.
21. Pizzo P, Viola A: Lymphocyte lipid rafts: structure and function. Curr Opin Immunol 2003;15:255-260.
22. Zhang W, et al: Functional analysis of LAT in TCR-mediated signaling pathways using a LAT-deficient Jurkat cell line. Int Immunol 1999;11:943-950.
23. Bromley SK, et al: The immunological synapse. Annu Rev Immunol 2001:19:375-396.
24. Dustin ML, Cooper JA: The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling. Nat Immunol 2000;1:23-29.
25. Grakoui A, et al: The immunological synapse: a molecular machine controlling T cell activation. Science 1999;285:221-227.
26. Monks CR, et al: Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 1998;395:82-86.
27. Lee KH, et al: T cell receptor signaling precedes immunological synapse formation. Science 2002;295: 1539-1542.
28. Fujikawa K, et al: Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J Exp Med 2003; 198:1595-1608.
29. Etienne-Manneville S, Hall A: Rho GTPases in cell biology. Nature 2002;420:629-635.
30. Bustelo XR, Ledbetter JA, Barbacid M: Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Nature 1992;356:68-71.
31. Margolis B, et al: Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs. Nature 1992;356:71-74.
32. Movilla N, Bustelo XR: Biological and regulatory properties of Vav-3, anew member of the Vav family of oncoproteins. Mol Cell Biol 1999;19:7870-7885.
33. Moores SL, et al: Vav family proteins couple to diverse cell surface receptors. Mol Cell Biol 2000;20: 6364-6373.
34. Fujikawa K, et al: Vav3 is regulated during the cell cycle and effects cell division. Proc Natl Acad Sci USA 2002;99:4313-4318.
35. Aghazadeh B, et al: Structural basis for relief of autoinhibition of the Db1 homology domain of proto-oncogene Vav by tyrosine phosphorylation. Cell 2000;102:625-633.
36. Kuhne MR, Ku G, Weiss A: A guanine nucleotide exchange factor-independent function of Vav1 in transcriptional activation. J Biol Chem 2000;275:2185-2190.
37. Han J, et al: Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 1998;279:558-560.
38. Han J, et al: Lck regulates Vav activation of members of the Rho family of GTPases. Mol Cell Biol 1997;17:1346-1353.
39. Zhang R, et al: Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 1995;374:470-473.
40. Tarakhovsky A, et al: Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 1995;374:467-470.
41. + thymocytes. Nature 1995;374:474-477.
42. Swat W, et al: Essential role for Vav1 in activation, but not development, of gammadelta T cells. Int Immunol 2003;15:215-221.
43. Holsinger LJ, et al: Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr Biol 1998;8: 563-572.
44. Doody GM, et al: Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation. Nat Immunol 2001;2:542-547.
45. Tedford K, et al: Compensation between Vav-1 and Vav2 in B cell development and antigen receptor signaling. Nat Immunol 2001;2:548-555.
46. Inabe K, et al: Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation. J Exp Med 2002;195:189-200.
47. Reynolds LF, et al: Vavl transduces T cell receptor signals to the activation of the Ras/ERK pathway via LAT, Sos, and RasGRP1. JBiol Chem 2004;279:18,239-18,246.
48. Reynolds LF, et al: Vav1 transduces T cell receptor signals to the activation of phospholipase C-gamma1 via phosphoinositide 3-kinase-dependent and -independent pathways. J Exp Med 2002;195:1103-1114.
49. Dower NA, et al: RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nat Immunol 2000;1:317-321.
50. Gong Q, et al: Disruption of T cell signaling networks and development by Grb2 haploid insufficiency. Nat Immunol 2001;2:29-36.
51. Raulet DH: Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003;3:781-790.
52. Cerwenka A, Lanier LL: Natural killer cells, viruses and cancer. Nat Rev Immunol 2001;1:41-49.
53. Perussia B: Signaling for cytotoxicity. Nat Immunol 2000;1:372-374.
54. Cella M, et al: Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J Exp Med 2004;200:817-823.
55. Gakidis MA, et al: Vav GEFs are required for beta2 integrin-dependent functions of neutrophils. J Cell Biol 2004;166:273-282.